title: Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction.
authors.affiliation: Division of Cardiology, George Washington University Medical Center, Washington, DC 20037, USA. ctracy@mfa.gwu.edu
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Tracy
mesh_terms: D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000401:mortality*; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality*; D018579:Patient Selection; D016016:Proportional Hazards Models; D013997:Time Factors